# Onebiopharma Inc. — Form D

Onebiopharma Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-17. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2019-05-17
- Form: D
- Accession: 0001776866-19-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 2
- Date of first sale: 2019-05-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-339833

## Issuer

- Name: Onebiopharma Inc.
- CIK: 0001776866
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 124 MARLBOROUGH STREET, BOSTON, MA, 02111
- Phone: 833 266 3246

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Elon Boms | Director | New Haven, CT |
| Amit Munshi | Director | Westlake Village, CA |
| Andrew Wingate | Director | Boston, MA |
| Michael Wyand | Director | Boston, MA |
| Michael Wyand | Executive Officer | Boston, MA |

## More

- [CIK 1776866 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1776866&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001776866-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.